Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. Dive into the research topics of 'High-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain'. Together they form a unique fingerprint. Practice Guideline Nursing and Health Professions. Thorax Pain Nursing and Health Professions.

  2. 12 maj 2021 · To identify the diagnoses and outcomes associated with elevated high sensitivity cardiac troponin T (hs-cTnT) compared with the 4th-generation troponin T and to validate the Mayo Clinic hs-cTnT myocardial infarction algorithm cutoff values. Patients and Methods.

  3. 14 lip 2022 · This primer discusses the use of high-sensitivity cardiac troponin (hs-cTn) testing in context of the 2021 multisociety guidelines for the evaluation and diagnosis of acute chest pain, with a notable focus on analytical aspects of the hs-cTn assays and their implications.

  4. 22 lis 2011 · Based on the 99th percentile rule, troponin decision limits of several high-sensitivity cTn assays can be set as low as 0.01 ng/mL. 6 This makes it possible to identify patients with ACS earlier, enabling earlier coronary intervention (Figure 2).

  5. Abstract. Objective: To identify the diagnoses and outcomes associated with elevated high sensitivity cardiac troponin T (hs-cTnT) compared with the 4th-generation troponin T and to validate the Mayo Clinic hs-cTnT myocardial infarction algorithm cutoff values.

  6. make important recommendations that include the recognition of high-sensitivity cardiac troponin (hs-cTn) as the preferred biomarker, endorsement of 99th percentile upper reference limits to define myocardial injury, and the use of clinical decision

  7. 1 lip 2022 · The recently published AHA/ACC guidelines 1 make important recommendations that include the recognition of hs-cTn as the preferred biomarker, endorsement of 99th percentile upper reference limits to define myocardial injury, the use of clinical decision pathways (CDPs), and acknowledgment of the uniqueness of women and other patient subsets.